Study Comparing the Effects of Sibutramine and Phentermine on Psychomotor Performance
Main Article Content
Abstract
Pharmacotherapy plays an important role in the management of obesity. At
present two drugs which act centrally are registered in Thailand; namely, sibutramine
and phentermine. In this study, the objective was to compare the effects of sibutramine
15 mg with phentermine 15 mg and placebo on psychomotor performance in Thai
healthy volunteers. A double blind, crossover studies with one week wash out interval
was performed in 20 Thai healthy volunteers aged between 18-65 years. During each
treatment psychomotor speed tests of warned and unwarned simple reaction time
(SRT) of visual, auditory and tactile types were measured. Phentermine shortened both
warned and unwarned simple reaction time (visual and auditory but not tactile simple
reaction time) significantly than sibutramine and placebo. Phentermine also
significantly increased diastolic blood pressure and pulse rate. These effects were also
related to the peak plasma concentration of orally extended release phentermine and
sibutramine. Adverse reactions including palpitation and insomnia were reported by
75% of subjects in phentermine-treated group and 40% in sibutramine-treated group.
This study indicated that phentermine acts as a CNS stimulant and may result in the
increase in blood pressure and pulse rate, while sibutramine produced much less
stimulating effects on the CNS and cardiovascular systems than phentermine.
Article Details
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.